In our study, using EPIC for immune deconvolution between primary and metastatic melanoma revealed a more heterogenous immune environment, especially in CD4+/CD8+ T cells and macrophages, reflecting varying immune surveillance. The gene discussed is CD8A; the disease is metastatic melanoma.